FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marinus van Oers

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Treatment Outcome

Physiology

Lymphocyte Activation

Anatomy

Living Beings

Human Herpesvirus 4

Co-author Network

Publications

TOP 3
Diana Wouters; Conny Brouwer; Masja de Haas; Anton Hagenbeek; Femke Stephan; Paul Strengers; Marinus H J van Oers; Sacha Zeerleder
C1-esterase inhibitor concentrate rescues erythrocytes from complement-mediated destruction in autoimmune hemolytic anemia.
Marinus H J van Oers
CD20 antibodies: type II to tango?
Jacqueline M Tromp; Jacoline van Laar; Marinus H J van Oers; Tim Beaumont; Esther C W Breij; Judith A Elias; Christian R Geest; Arnon P Kater; Dieuwertje M Luijks; Eric Eldering
Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marinus van Oers (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Diana Wouters; Conny Brouwer; Masja de Haas; Anton Hagenbeek; Femke Stephan; Paul Strengers; Marinus H J van Oers; Sacha Zeerleder
C1-esterase inhibitor concentrate rescues erythrocytes from complement-mediated destruction in autoimmune hemolytic anemia.
Blood 2013;121(7):1242-4.
2012: Marinus H J van Oers
CD20 antibodies: type II to tango?
Blood 2012;119(22):5061-3.
2012: Jacqueline M Tromp; Jacoline van Laar; Marinus H J van Oers; Tim Beaumont; Esther C W Breij; Judith A Elias; Christian R Geest; Arnon P Kater; Dieuwertje M Luijks; Eric Eldering
Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(2):487-98.
2011: Daniel W Hommes; Marjolijn Duijvestein; Maartje Holsbergen-de Ley; Jaap Stoker; Pieter C F Stokkers; Marinus H J van Oers; Carlijn Voermans; Zuzana Zelinkova; Marie José Kersten
Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's disease.
Journal of Crohn's & colitis 2011;5(6):543-9.
2011: Margot Jak; Wouter W Kallemeijn; Christian Klein; Eric A Reits; Jacqueline M Tromp; Pablo Umana; Gregor G W van Bochove; Rene A W van Lier; Marinus H J van Oers; Eric Eldering
CD40 stimulation sensitizes CLL cells to lysosomal cell death induction by type II anti-CD20 mAb GA101.
Blood 2011;118(19):5178-88.
2011: Marinus H J van Oers; Marie José Kersten
Treatment strategies in advanced stage follicular lymphoma.
Best practice & research. Clinical haematology 2011;24(2):187-201.
2011: S H Tonino; J van Laar; Marinus H J van Oers; J Y Wang; Eric Eldering; Arnon P Kater
ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia.
Oncogene 2011;30(6):701-13.
2010: Bertrand Coiffier; Nedjad Losic; Birgitte Biilmann Rønn; Stéphane Lepretre; Lars Møller Pedersen; Ole Gadeberg; Henrik Frederiksen; Marinus H J van Oers; James E Wooldridge; Janusz Kloczko; Jerzy Holowiecki; Andrzej Hellmann; Jan Walewski; Tadeusz Robak; Jørgen Petersen
Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1-2 study.
British journal of haematology 2010;150(1):58-71.
2010: Reinier H van Rijssel; Jurgen Wegman; Monique E Oud; Steven T Pals; Marinus H J van Oers
A case of ATRA-induced isolated myocarditis in the absence of circulating malignant cells: demonstration of the t(15;17) translocation in the inflammatory infiltrate by in situ hybridisation.
Leukemia research 2010;34(7):e142-4.
2010: Marinus H J van Oers; Martine Van Glabbeke; Livia Giurgea; Richard J Klasa; Robert E Marcus; Max Wolf; Eva Kimby; Mars van t Veer; Andrej Vranovsky; Harald Holte; Anton Hagenbeek
Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(17):2853-8.
2010: Marinus H J van Oers; Evelyn Tönnissen; Martine Van Glabbeke; Livia Giurgea; Joop H Jansen; Richard J Klasa; Robert E Marcus; Max Wolf; Eva Kimby; Andrej Vranovsky; Harald Holte; Anton Hagenbeek; Bert A van der Reijden
BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(13):2246-52.
2010: Evelien Kneppers; Henk M Lokhorst; Corien M Eeltink; Gerwin Huls; Marie José Kersten; Jan Koedam; Monique C Minnema; Marinus H J van Oers; Reinier A P Raymakers; Martijn R Schaafsma; Edo Vellenga; Pierre W Wijermans; Shulamiet Wittebol; Pieter Sonneveld; Sonja Zweegman
Analysis of efficacy and prognostic factors of lenalidomide treatment as part of a Dutch compassionate use program.
Clinical lymphoma, myeloma & leukemia 2010;10(2):138-43.
2010: S H Tonino; M van Gelder; Eric Eldering; Marinus H J van Oers; Arnon P Kater
R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia.
Leukemia 2010;24(3):652-4.
2010: Henk M Lokhorst; Bronno van der Holt; Sonja Zweegman; Edo Vellenga; Sandra Croockewit; Marinus H J van Oers; Peter von dem Borne; Pierre W Wijermans; Ron Schaafsma; Okke de Weerdt; Shulamiet Wittebol; Michel Delforge; Henriëtte Berenschot; Gerard M Bos; Kon-Siong G Jie; Harm Sinnige; Marinus van Marwijk Kooy; Peter Joosten; Monique C Minnema; Rianne van Ammerlaan; Pieter Sonneveld
A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma.
Blood 2010;115(6):1113-20.
2010: Yavuz M Bilgin; Leo M G van de Watering; Michel I M Versteegh; Marinus H J van Oers; Anneke Brand
Effects of allogeneic leukocytes in blood transfusions during cardiac surgery on inflammatory mediators and postoperative complications.
Critical care medicine 2010;38(2):546-52.
2010: Alexander P J Vlaar; Kim Wortel; Jan M Binnekade; Marinus H J van Oers; Erik Beckers; ognjen gajic; Marcus J Schultz; Nicole P Juffermans
The practice of reporting transfusion-related acute lung injury: a national survey among clinical and preclinical disciplines.
Transfusion 2010;50(2):443-51.
2009: Shelly R Gunn; Aswani R Bolla; Lynn L Barron; Mercedes E Gorre; Mansoor S Mohammed; David W Bahler; Clemens H M Mellink; Marinus H J van Oers; Michael J Keating; Alessandra Ferrajoli; Kevin R Coombes; Lynne V Abruzzo; Ryan S Robetorye
Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME gene.
Leukemia research 2009;33(9):1276-81.
2009: Margot Jak; Rogier Mous; Ester B M Remmerswaal; René Spijker; Annelieke Jaspers; Adriana Yagüe; Eric Eldering; René A W Van Lier; Marinus H J van Oers
Enhanced formation and survival of CD4+ CD25hi Foxp3+ T-cells in chronic lymphocytic leukemia.
Leukemia & lymphoma 2009;50(5):788-801.
2009: Thorsten Zenz; Julia Mohr; Eric Eldering; Arnon P Kater; Andreas Bühler; Dirk Kienle; Dirk Winkler; Jan Dürig; Marinus H J van Oers; Daniel Mertens; Hartmut Döhner; Stephan Stilgenbauer
miR-34a as part of the resistance network in chronic lymphocytic leukemia.
Blood 2009;113(16):3801-8.
2009: Jan J Cornelissen; Bronno van der Holt; Gregor Verhoef; Mars B van't Veer; Marinus H J van Oers; Harry C Schouten; Gert Ossenkoppele; Pieter Sonneveld; Johan Maertens; Marinus van Marwijk Kooy; M Ronald Schaafsma; Pierre W Wijermans; Douwe H Biesma; Shulamiet Wittebol; Paul J Voogt; Joke W Baars; Pierre Zachée; Leo F Verdonck; Bob Löwenberg; Adriaan W Dekker
Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison.
Blood 2009;113(6):1375-82.
2009: Mars B van 't Veer; Daphne de Jong; Marius MacKenzie; Hanneke C Kluin-Nelemans; Marinus H J van Oers; Jose Zijlstra; Anton Hagenbeek; Wim L J van Putten
High-dose Ara-C and beam with autograft rescue in R-CHOP responsive mantle cell lymphoma patients.
British journal of haematology 2009;144(4):524-30.
2008: Delfine Y H Hallaert; Annelieke Jaspers; Carel J van Noesel; Marinus H J van Oers; Arnon P Kater; Eric Eldering
c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches.
Blood 2008;112(13):5141-9.
2008: Franck Morschhauser; John Radford; Achiel Van Hoof; Umberto Vitolo; Pierre Soubeyran; Hervé Tilly; Peter C Huijgens; Arne Kolstad; Francesco d'Amore; Marcos Gonzalez Diaz; Mario Petrini; Catherine Sebban; Pier Luigi Zinzani; Marinus H J van Oers; Wim van Putten; Angelika Bischof Delaloye; Ama Rohatiner; Gilles SALLES; Jens Kuhlmann; Anton Hagenbeek
Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(32):5156-64.
2008: Shelly R Gunn; Mansoor S Mohammed; Mercedes E Gorre; Philip D Cotter; Jaeweon Kim; David W Bahler; Sergey N Preobrazhensky; Russell A Higgins; Aswani R Bolla; Sahar H Ismail; Daphne de Jong; Eric Eldering; Marinus H J van Oers; Clemens H M Mellink; Michael J Keating; Ellen J Schlette; Lynne V Abruzzo; Ryan S Robetorye
Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia.
The Journal of molecular diagnostics : JMD 2008;10(5):442-51.
2008: Rogier Mous; Philip Savage; Eric Eldering; Peter Teeling; Marinus H J van Oers; René Aw van Lier
Adequate synapse formation between leukemic B cells and effector T cells following stimulation with artificial TCR ligands.
Leukemia & lymphoma 2008;49(8):1592-602.
2008: Sanne H Tonino; rene spijker; Dieuwertje M P Luijks; Marinus H J van Oers; Arnon P Kater
No convincing evidence for a role of CD31-CD38 interactions in the pathogenesis of chronic lymphocytic leukemia.
Blood 2008;112(3):840-3.
2008: Bertrand Coiffier; Stéphane Lepretre; Lars Møller Pedersen; Ole Gadeberg; Henrik Fredriksen; Marinus H J van Oers; James E Wooldridge; Janusz Kloczko; Jerzy Holowiecki; Andrzej Hellmann; Jan Walewski; Mimi Flensburg; Jørgen Petersen; Tadeusz Robak
Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study.
Blood 2008;111(3):1094-100.
2008: Erwan Piriou; Karel van Dort; Sigrid Otto; Marinus H J van Oers; Debbie van Baarle
Tight regulation of the Epstein-Barr virus setpoint: interindividual differences in Epstein-Barr virus DNA load are conserved after HIV infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(2):313-6.
2008: Edo Vellenga; Wim L J van Putten; Mars B van 't Veer; Josée M Zijlstra; Willem E Fibbe; Marinus H J van Oers; Leo F Verdonck; Pierre W Wijermans; Gustaaf W van Imhoff; Pieternella J Lugtenburg; Peter C Huijgens
Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.
Blood 2008;111(2):537-43.
2008: Henk M Lokhorst; Ingo Schmidt-Wolf; Pieter Sonneveld; Bronno van der Holt; Hans Martin; Renée M Y Barge; Uta Bertsch; Jana Schlenzka; Gerard M J Bos; Sandra Croockewit; Sonja Zweegman; Iris Breitkreutz; Iris Breitkreuz; Peter Joosten; Christof Scheid; Marinus van Marwijk Kooy; Hans Salwender; Marinus H J van Oers; Ron Schaafsma; Ralph Naumann; Harm Sinnige; Igor Blau; Michel Delforge; Gregor Verhoef; Okke de Weerdt; Pierre W Wijermans; Shulamiet Wittebol; Ulrich Duersen; Edo Vellenga; Hartmut Goldschmidt
Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma.
Haematologica 2008;93(1):124-7.
2007: Saskia K Klein; Bart J Biemond; Marinus H J van Oers
Two cases of isolated symptomatic myocarditis induced by all-trans retinoic acid (ATRA).
Annals of hematology 2007;86(12):917-8.
2007: D Y H Hallaert; rene spijker; M Jak; Ingrid A M Derks; Nuno L Alves; F M Wensveen; Jan Paul de Boer; Daphne de Jong; S R Green; Marinus H J van Oers; Eric Eldering
Crosstalk among Bcl-2 family members in B-CLL: seliciclib acts via the Mcl-1/Noxa axis and gradual exhaustion of Bcl-2 protection.
Cell death and differentiation 2007;14(11):1958-67.
2007: Arnon P Kater; Marinus H J van Oers; Thomas Kipps
Cellular immune therapy for chronic lymphocytic leukemia.
Blood 2007;110(8):2811-8.
2007: Marinus H J van Oers
Rituximab maintenance in indolent lymphoma: indications and controversies.
Current oncology reports 2007;9(5):378-83.
2007: K de Heer; M H Silbermann; HR Koene; Bart J Biemond; H P Muller; Marinus H J van Oers
[Systematic diagnosis of erythrocytosis].
Nederlands tijdschrift voor geneeskunde 2007;151(32):1770-6.
2007: YM Bilgin; L M G van de Watering; L Eijsman; Michel I M Versteegh; Marinus H J van Oers; Anneke Brand
Is increased mortality associated with post-operative infections after leukocytes containing red blood cell transfusions in cardiac surgery? An extended analysis.
Transfusion medicine (Oxford, England) 2007;17(4):304-11.
2007: Pieter Sonneveld; Bronno van der Holt; Christine M Segeren; Edo Vellenga; Alexandra J Croockewit; Gregor E G Verhoe; Jan J Cornelissen; M Ronald Schaafsma; Marinus H J van Oers; Pierre W Wijermans; Petra H M Westveer; Henk M Lokhorst
Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial.
Haematologica 2007;92(7):928-35.
2007: Marinus H J van Oers
Rituximab maintenance therapy: a step forward in follicular lymphoma.
Haematologica 2007;92(6):826-33.
2007: Michiel F van Oosterwijk; Hedi Juwana; Ramon Arens; kiki tesselaar; Marinus H J van Oers; Eric Eldering; René A W van Lier
CD27-CD70 interactions sensitise naive CD4+ T cells for IL-12-induced Th1 cell development.
International immunology 2007;19(6):713-8.
2007: Laura A Smit; Delfine Y H Hallaert; rene spijker; Bart de Goeij; Annelieke Jaspers; Arnon P Kater; Marinus H J van Oers; Carel J M van Noesel; Eric Eldering
Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity.
Blood 2007;109(4):1660-8.
2006: Marinus H J van Oers; Richard J Klasa; Robert E Marcus; Max Wolf; Eva Kimby; Randy D Gascoyne; Andrew Jack; Mars B van't Veer; Andrej Vranovsky; Harald Holte; Martine Van Glabbeke; Ivana Teodorovic; Cynthia Rozewicz; Anton Hagenbeek
Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial.
Blood 2006;108(10):3295-301.
2006: Catharina W Wieland; Marjolein E Kerver; Sandrine Florquin; Martijn A Nolte; Jannie Borst; René A W van Lier; Marinus H J van Oers; Tom van der Poll
CD27 contributes to the early systemic immune response to Mycobacterium tuberculosis infection but does not affect outcome.
International immunology 2006;18(11):1531-9.
2006: Niels W C J van de Donk; Nicolaus Kröger; Ute Hegenbart; Paolo Corradini; Jesús F San Miguel; Hartmut Goldschmidt; Jose A Perez-Simon; Maeike Zijlmans; Reinier A P Raymakers; Vittorio Montefusco; Francis Ayuk; Marinus H J van Oers; Arnon Nagler; Leo F Verdonck; Henk M Lokhorst
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma.
Bone marrow transplantation 2006;37(12):1135-41.
2006: R Mous; P Savage; Ester B M Remmerswaal; René A W van Lier; Eric Eldering; Marinus H J van Oers
Redirection of CMV-specific CTL towards B-CLL via CD20-targeted HLA/CMV complexes.
Leukemia 2006;20(6):1096-102.
2006: Niels W C J van de Donk; Nicolaus Kröger; Ute Hegenbart; Paolo Corradini; Jesús F San Miguel; Hartmut Goldschmidt; Jose A Perez-Simon; Maeike Zijlmans; Reinier A P Raymakers; Vittorio Montefusco; Francis Ayuk; Marinus H J van Oers; Arnon Nagler; Leo F Verdonck; Henk M Lokhorst
Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.
Blood 2006;107(8):3415-6.
2006: Erwan Piriou; Karel van Dort; Jan F L Weel; Frederike J Bemelman; Laila E Gamadia; Marinus H J van Oers; Debbie Van Baarle
Detailed kinetics of EBV-specific CD4+ and CD8+ T cells during primary EBV infection in a kidney transplant patient.
Clinical immunology (Orlando, Fla.) 2006;119(1):16-20.
2005: Erwan Piriou; Karel van Dort; Nening M Nanlohy; Marinus H J van Oers; Frank Miedema; Debbie Van Baarle
Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma.
Blood 2005;106(9):3166-74.
2005: Erwan Piriou; Christine A Jansen; Karel van Dort; Iris M De Cuyper; Nening M Nanlohy; Joep M A Lange; Marinus H J van Oers; Frank Miedema; Debbie Van Baarle
Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(3):2010-7.
2005: M van Hulst; YM Bilgin; L M G van de Watering; R de Vries; Marinus H J van Oers; Anneke Brand; Maarten J Postma
Cost-effectiveness of leucocyte-depleted erythrocyte transfusion in cardiac valve surgery.
Transfusion medicine (Oxford, England) 2005;15(3):209-17.
2005: Gustaaf W van Imhoff; Bronno van der Holt; Marius A Mackenzie; Gert Ossenkoppele; Pierre W Wijermans; Mark H H Kramer; Mars B van 't Veer; Harry C Schouten; Marinus van Marwijk Kooy; Marinus H J van Oers; John M M Raemaekers; Pieter Sonneveld; L A M H Meulendijks; Philip M Kluin; Hanneke C Kluin-Nelemans; Leo F Verdonck
Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma.
Leukemia 2005;19(6):945-52.
2005: Ramon Arens; Paul A Baars; Margot Jak; kiki tesselaar; Martin van der Valk; Marinus H J van Oers; René A W van Lier
Cutting edge: CD95 maintains effector T cell homeostasis in chronic immune activation.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(10):5915-20.
2005: Martijn A Nolte; Ramon Arens; Ronald van Os; Michiel F van Oosterwijk; Berend Hooibrink; René A W van Lier; Marinus H J van Oers
Immune activation modulates hematopoiesis through interactions between CD27 and CD70.
Nature immunology 2005;6(4):412-8.
2005: Erwan Piriou; Karel van Dort; Nening M Nanlohy; Marinus H J van Oers; Frank Miedema; Debbie Van Baarle
Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
European journal of immunology 2005;35(3):796-805.
2005: Wendelina J M Mackus; Arnon P Kater; Annette Grummels; Ludo M Evers; B Hooijbrink; Mark H H Kramer; Januario E Castro; Thomas Kipps; René A W van Lier; Marinus H J van Oers; Eric Eldering
Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation.
Leukemia 2005;19(3):427-34.
2004: Arnon P Kater; Ludo M Evers; Ester B M Remmerswaal; Annelieke Jaspers; Michiel F Oosterwijk; René A W van Lier; Marinus H J van Oers; Eric Eldering
CD40 stimulation of B-cell chronic lymphocytic leukaemia cells enhances the anti-apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic T-lymphocyte attack.
British journal of haematology 2004;127(4):404-15.
2004: Ramon Arens; Martijn A Nolte; kiki tesselaar; Bianca Heemskerk; Kris A Reedquist; René A W van Lier; Marinus H J van Oers
Signaling through CD70 regulates B cell activation and IgG production.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(6):3901-8.
2004: Arnon P Kater; Ester B M Remmerswaal; Martijn A Nolte; Eric Eldering; Marinus H J van Oers; René A W van Lier
Autologous cytomegalovirus-specific T cells as effector cells in immunotherapy of B cell chronic lymphocytic leukaemia.
British journal of haematology 2004;126(4):512-6.
2004: Eric Eldering; Wendelina J M Mackus; Ingrid A M Derks; Ludo M Evers; Esther Beuling; Peter Teeling; Susanne M A Lens; Marinus H J van Oers; René A W van Lier
Apoptosis via the B cell antigen receptor requires Bax translocation and involves mitochondrial depolarization, cytochrome C release, and caspase-9 activation.
European journal of immunology 2004;34(7):1950-60.
2004: YM Bilgin; L M G van de Watering; L Eijsman; Michel I M Versteegh; Ronald Brand; Marinus H J van Oers; Anneke Brand
Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery.
Circulation 2004;109(22):2755-60.
2004: Ramon Arens; Koen Schepers; Martijn A Nolte; Michiel F van Oosterwijk; René A W van Lier; Schumacher Ton; Marinus H J van Oers
Tumor rejection induced by CD70-mediated quantitative and qualitative effects on effector CD8+ T cell formation.
The Journal of experimental medicine 2004;199(11):1595-605.
2004: Erwan Piriou; Karel van Dort; Nening M Nanlohy; Frank Miedema; Marinus H J van Oers; Debbie Van Baarle
Altered EBV viral load setpoint after HIV seroconversion is in accordance with lack of predictive value of EBV load for the occurrence of AIDS-related non-Hodgkin lymphoma.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(11):6931-7.
2004: Henk M Lokhorst; Kalung Wu; Leo F Verdonck; Laurens Laterveer; Niels W C J van de Donk; Marinus H J van Oers; Jan J Cornelissen; A V M B Schattenberg
The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma.
Blood 2004;103(11):4362-4.
2004: Patrick W B Derksen; Esther P M Tjin; Helen P Meijer; Melanie D Klok; Harold D MacGillavry; Marinus H J van Oers; Henk M Lokhorst; Andries C Bloem; Hans Clevers; Roel Nusse; Ronald van der Neut; Marcel Spaargaren; Steven T Pals
Illegitimate WNT signaling promotes proliferation of multiple myeloma cells.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(16):6122-7.
2004: Martijn A Nolte; Ramon Arens; Manfred Kraus; Marinus H J van Oers; Georg Kraal; René A W van Lier; Reina E Mebius
B cells are crucial for both development and maintenance of the splenic marginal zone.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(6):3620-7.
2003: Jeanette K Doorduijn; Bronno van der Holt; Gustaaf W van Imhoff; Klaas G van der Hem; Mark H H Kramer; Marinus H J van Oers; Gert Ossenkoppele; M Ronald Schaafsma; Leo F Verdonck; Gregor Verhoef; Monique M C Steijaert; Ivonne Buijt; Carin A Uyl-de Groot; Michel van Agthoven; Andries H Mulder; Pieter Sonneveld
CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3041-50.
2003: Lizet E van der Kolk; AJ Grillo-López; Joke W Baars; Marinus H J van Oers
Treatment of relapsed B-cell non-Hodgkin's lymphoma with a combination of chimeric anti-CD20 monoclonal antibodies (rituximab) and G-CSF: final report on safety and efficacy.
Leukemia 2003;17(8):1658-64.
2003: Wendelina J M Mackus; Florine N J Frakking; Annette Grummels; Laila E Gamadia; Godelieve J De Bree; Dörte Hamann; René A W van Lier; Marinus H J van Oers
Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia.
Blood 2003;102(3):1057-63.
2003: Rick L M Haas; Philip Poortmans; Daphne de Jong; Berthe M P Aleman; L G H Dewit; Marcel Verheij; Augustinus A M Hart; Marinus H J van Oers; Marleen van der Hulst; Joke W Baars; Harry Bartelink
High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(13):2474-80.
2003: Henk M Lokhorst; Christine M Segeren; Leo F Verdonck; Bronno van der Holt; Reinier A P Raymakers; Marinus H J van Oers; Renée M Y Barge; Harry C Schouten; Petra H M Westveer; Monique M C Steijaert; Jan J Cornelissen; Pieter Sonneveld
Partially T-cell-depleted allogeneic stem-cell transplantation for first-line treatment of multiple myeloma: a prospective evaluation of patients treated in the phase III study HOVON 24 MM.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1728-33.
2003: Christine M Segeren; Pieter Sonneveld; Bronno van der Holt; Edo Vellenga; Alexandra J Croockewit; Gregor Verhoef; Jan J Cornelissen; M Ronald Schaafsma; Marinus H J van Oers; Pierre W Wijermans; Wim E Fibbe; Shulamiet Wittebol; Harry C Schouten; Marinus van Marwijk Kooy; Douwe H Biesma; Joke W Baars; Rosalyn Slater; Monique M C Steijaert; Ivonne Buijt; Henk M Lokhorst
Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study.
Blood 2003;101(6):2144-51.
2003: Arnon P Kater; Marinus H J van Oers
[Chronic lymphocytic leukemia: high time for a risk-adapted approach].
Nederlands tijdschrift voor geneeskunde 2003;147(3):104-9.
2003: kiki tesselaar; Ramon Arens; Gijs M W van Schijndel; Paul A Baars; Martin A van der Valk; Jannie Borst; Marinus H J van Oers; René A W van Lier
Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions.
Nature immunology 2003;4(1):49-54.
2002: Debbie Van Baarle; Stefan Kostense; Marinus H J van Oers; Dörte Hamann; Frank Miedema
Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue.
Trends in immunology 2002;23(12):586-91.
2002: Debbie Van Baarle; Stefan Kostense; Egbert Hovenkamp; Graham S Ogg; Nening M Nanlohy; Margaret F C Callan; Nicole Dukers; Andrew J McMichael; Marinus H J van Oers; Frank Miedema
Lack of Epstein-Barr virus- and HIV-specific CD27- CD8+ T cells is associated with progression to viral disease in HIV-infection.
AIDS (London, England) 2002;16(15):2001-11.
2002: Marinus H J van Oers; Anton Hagenbeek; Martine Van Glabbeke; Ivana Teodorovic
Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma: a phase III randomized clinical trial--Intergroup Collaborative Study.
Annals of hematology 2002;81(10):553-7.
2002: Lizet E van der Kolk; Joke W Baars; Martin H Prins; Marinus H J van Oers
Rituximab treatment results in impaired secondary humoral immune responsiveness.
Blood 2002;100(6):2257-9.
2002: Lizet E van der Kolk; Ludo M Evers; CO Omene; Susanne M A Lens; S Lederman; René A W van Lier; Marinus H J van Oers; Eric Eldering
CD20-induced B cell death can bypass mitochondria and caspase activation.
Leukemia 2002;16(9):1735-44.
2002: Debbie Van Baarle; Katja C Wolthers; Egbert Hovenkamp; Hubert G M Niesters; Albert D M E Osterhaus; Frank Miedema; Marinus H J van Oers
Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma.
The Journal of infectious diseases 2002;186(3):405-9.
2002: Lizet E van der Kolk; M de Haas; AJ Grillo-López; Joke W Baars; Marinus H J van Oers
Analysis of CD20-dependent cellular cytotoxicity by G-CSF-stimulated neutrophils.
Leukemia 2002;16(4):693-9.
2002: Stefan Kostense; Sigrid A Otto; Gerlinde J Knol; Erik H Manting; Nening M Nanlohy; Christine Jansen; Joep M A Lange; Marinus H J van Oers; Frank Miedema; Debbie Van Baarle
Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
European journal of immunology 2002;32(4):1080-9.
2002: H J J van der Vliet; Marinus H J van Oers; L J Schot; Charles B L M Majoie; J T M van der Meer
A space-occupying lesion of the skull base, masked by nasopharyngeal lymphatic tissue hypertrophy and causing cranial nerve dysfunction in an HIV-infected patient.
Annals of hematology 2002;81(3):164-6.
2002: Patrick W B Derksen; Robert M J Keehnen; Ludo M Evers; Marinus H J van Oers; Marcel Spaargaren; Steven T Pals
Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma.
Blood 2002;99(4):1405-10.
2001: Lizet E van der Kolk; AJ Grillo-López; Joke W Baars; C Erik Hack; Marinus H J van Oers
Complement activation plays a key role in the side-effects of rituximab treatment.
British journal of haematology 2001;115(4):807-11.
2001: Ramon Arens; kiki tesselaar; Paul A Baars; Gijs M W van Schijndel; Jenny Hendriks; Steven T Pals; Paul Krimpenfort; Jannie Borst; Marinus H J van Oers; René A W van Lier
Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion.
Immunity 2001;15(5):801-12.
2001: Edo Vellenga; Michel van Agthoven; Alexandra J Croockewit; Leo F Verdonck; P J Wijermans; Marinus H J van Oers; Corine P Volkers; Gustaaf W van Imhoff; T Kingma; Carin A Uyl-de Groot; W E Fibbe
Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study.
British journal of haematology 2001;114(2):319-26.
2001: Debbie Van Baarle; Egbert Hovenkamp; Margaret F C Callan; Katja C Wolthers; Stefan Kostense; LC Tan; Hubert G M Niesters; Albert D M E Osterhaus; Andrew J McMichael; Marinus H J van Oers; Frank Miedema
Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma.
Blood 2001;98(1):146-55.
2001: J van der Lelie; Marinus H J van Oers; A E von dem Borne
[Diagnostics for classification of anemia].
Nederlands tijdschrift voor geneeskunde 2001;145(18):866-9.
2000: Henk M Lokhorst; A V M B Schattenberg; Jan J Cornelissen; Marinus H J van Oers; Willem E Fibbe; I Russell; N W Donk; Leo F Verdonck
Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(16):3031-7.
2000: Debbie Van Baarle; Egbert Hovenkamp; Nicole Dukers; Neil Renwick; Marie José Kersten; Jaap Goudsmit; Roel A Coutinho; Frank Miedema; Marinus H J van Oers
High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission.
The Journal of infectious diseases 2000;181(6):2045-9.
1999: SM Lens; Paul Drillenburg; Bianca den Drijver; Gijs M W van Schijndel; Steven T Pals; René A W van Lier; Marinus H J van Oers
Aberrant expression and reverse signalling of CD70 on malignant B cells.
British journal of haematology 1999;106(2):491-503.
1999: Debbie Van Baarle; Egbert Hovenkamp; Marie José Kersten; Michel Klein; Frank Miedema; Marinus H J van Oers
Direct Epstein-Barr virus (EBV) typing on peripheral blood mononuclear cells: no association between EBV type 2 infection or superinfection and the development of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma.
Blood 1999;93(11):3949-55.
1999: Christine M Segeren; Pieter Sonneveld; Bronno van der Holt; Joke W Baars; Douwe H Biesma; J J Cornellissen; Alexandra J Croockewit; Adriaan W Dekker; W E Fibbe; Bob Löwenberg; Marinus van Marwijk Kooy; Marinus H J van Oers; D J Richel; H C Schouten; Edo Vellenga; Gregor Verhoef; Pierre W Wijermans; Shulamiet Wittebol; Henk M Lokhorst
Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma.
British journal of haematology 1999;105(1):127-30.
1999: Marie José Kersten; Sugianto Surachno; M G Koopman; L J van 't Veer; Steven T Pals; Marinus H J van Oers
[Epstein-Barr virus in a donor kidney as a cause of non-Hodgkin lymphoma].
Nederlands tijdschrift voor geneeskunde 1999;143(7):360-4.
1999: Henk M Lokhorst; Pieter Sonneveld; Jan J Cornelissen; Peter Joosten; Marinus van Marwijk Kooy; J Meinema; H Karel Nieuwenhuis; Marinus H J van Oers; D J Richel; C N Segeren; G Veth; Leo F Verdonck; Pierre W Wijermans
Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma.
Bone marrow transplantation 1999;23(4):317-22.
1998: SM Lens; kiki tesselaar; Marinus H J van Oers; René A W van Lier
Control of lymphocyte function through CD27-CD70 interactions.
Seminars in immunology 1998;10(6):491-9.
1998: HC van Zaanen; Henk M Lokhorst; Lucien A Aarden; H J Rensink; SO Warnaar; Marinus H J van Oers
Blocking interleukin-6 activity with chimeric anti-IL6 monoclonal antibodies in multiple myeloma: effects on soluble IL6 receptor and soluble gp130.
Leukemia & lymphoma 1998;31(5-6):551-8.
1998: Marie José Kersten; T J Verduyn; P Reiss; Ludo M Evers; F de Wolf; Marinus H J van Oers
Treatment of AIDS-related non-Hodgkin's lymphoma with chemotherapy (CNOP) and r-hu-G-CSF: clinical outcome and effect on HIV-1 viral load.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(10):1135-8.
1998: D Venema; M Schut; Marinus H J van Oers
[Lack of adherence to the guidelines on the use of fresh frozen plasma].
Nederlands tijdschrift voor geneeskunde 1998;142(36):1999-2002.
1998: HC van Zaanen; Henk M Lokhorst; Lucien A Aarden; H J Rensink; SO Warnaar; J van der Lelie; Marinus H J van Oers
Chimaeric anti-interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose-escalating study.
British journal of haematology 1998;102(3):783-90.
1998: Marie José Kersten; J Van Gorp; Steven T Pals; F Boon; Marinus H J van Oers
Expression of Epstein-Barr virus latent genes and adhesion molecules in AIDS-related non-Hodgkin's lymphomas: correlation with histology and CD4-cell number.
Leukemia & lymphoma 1998;30(5-6):515-24.
1998: SM Lens; Bianca den Drijver; A J Pötgens; kiki tesselaar; Marinus H J van Oers; René A W van Lier
Dissection of pathways leading to antigen receptor-induced and Fas/CD95-induced apoptosis in human B cells.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(12):6083-92.
1998: Carla E M Hollak; johannes aerts; Marinus H J van Oers
Alglucerase: practical guidance on appropriate dosage and administration in patients with Gaucher disease.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 1998;9(1):11-23.
1997: Marie José Kersten; S de Jong; Ludo M Evers; HR Koene; Marinus H J van Oers
Addition of granulocyte colony-stimulating factor to chemotherapy in patients with AIDS-related lymphoma: effects on neutrophil Fc gamma receptor expression and soluble Fc gammaRIII plasma levels.
British journal of haematology 1997;99(3):537-41.
1997: HC van Zaanen; Johannes A Romijn; Hans P Sauerwein; Henk M Lokhorst; SO Warnaar; Lucien A Aarden; Erik Endert; Marinus H J van Oers
Modulation of chronic excessive interleukin-6 production in multiple myeloma does not affect thyroid hormone concentrations.
Metabolism: clinical and experimental 1997;46(11):1343-8.
1997: Carla E M Hollak; E P Corssmit; johannes aerts; Erik Endert; Hans P Sauerwein; Johannes A Romijn; Marinus H J van Oers
Differential effects of enzyme supplementation therapy on manifestations of type 1 Gaucher disease.
The American journal of medicine 1997;103(3):185-91.
1997: Carla E M Hollak; Ludo M Evers; johannes aerts; Marinus H J van Oers
Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease.
Blood cells, molecules & diseases 1997;23(2):201-12.
1997: Marie José Kersten; Michel Klein; AM Holwerda; Frank Miedema; Marinus H J van Oers
Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-Hodgkin's lymphoma.
The Journal of clinical investigation 1997;99(7):1525-33.
1997: J van der Lelie; D Venema; Ed J Kuijper; RP van Steenwijk; Marinus H J van Oers; L L Thomas; A E von dem Borne
Pneumocystis carinii pneumonia in HIV-negative patients with haematologic disease.
Infection 1997;25(2):78-81.
1997: Carla E M Hollak; M Levi; F Berends; johannes aerts; Marinus H J van Oers
Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy.
British journal of haematology 1997;96(3):470-6.
1997: Rolf G Boot; Carla E M Hollak; Marri Verhoek; P Sloof; B J H M Poorthuis; Wim J Kleijer; Ron A Wevers; Marinus H J van Oers; marcel mannens; johannes aerts; Sonja van Weely
Glucocerebrosidase genotype of Gaucher patients in The Netherlands: limitations in prognostic value.
Human mutation 1997;10(5):348-58.
1997: SM Lens; Paul A Baars; Berend Hooibrink; Marinus H J van Oers; René A W van Lier
Antigen-presenting cell-derived signals determine expression levels of CD70 on primed T cells.
Immunology 1997;90(1):38-45.
1996: Helen Michelakakis; C Spanou; A Kondyli; Evagelia Dimitriou; Sonja van Weely; Carla E M Hollak; Marinus H J van Oers; johannes aerts
Plasma tumor necrosis factor-a (TNF-a) levels in Gaucher disease.
Biochimica et biophysica acta 1996;1317(3):219-22.
1996: SM Lens; R de Jong; Berend Hooibrink; Gerrit Koopman; Steven T Pals; Marinus H J van Oers; René A W van Lier
Phenotype and function of human B cells expressing CD70 (CD27 ligand).
European journal of immunology 1996;26(12):2964-71.
1996: H C van Zaanen; R P Koopmans; Lucien A Aarden; H J Rensink; J M Stouthard; S O Warnaar; Henk M Lokhorst; Marinus H J van Oers
Endogenous interleukin 6 production in multiple myeloma patients treated with chimeric monoclonal anti-IL6 antibodies indicates the existence of a positive feed-back loop.
The Journal of clinical investigation 1996;98(6):1441-8.
1996: Carla E M Hollak; Marinus H J van Oers; P Maaswinkel; johannes aerts; R Goudsmit
[The treatment of Gaucher's disease in The Netherlands using enzyme substitution therapy].
Nederlands tijdschrift voor geneeskunde 1996;140(19):1011-3.
1996: SM Lens; Robert M J Keehnen; Marinus H J van Oers; René A W van Lier; Steven T Pals; Gerrit Koopman
Identification of a novel subpopulation of germinal center B cells characterized by expression of IgD and CD70.
European journal of immunology 1996;26(5):1007-11.
1996: Carla E M Hollak; R Goudsmit; Marinus H J van Oers
Low-dose versus high-frequency regimens in Gaucher's disease.
Lancet 1996;347(8998):406-7.
1996: SM Lens; kiki tesselaar; B F den Drijver; Marinus H J van Oers; René A W van Lier
A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(2):507-14.
1995: EP Corssmit; Carla E M Hollak; Erik Endert; Marinus H J van Oers; Hans P Sauerwein; Johannes A Romijn
Increased basal glucose production in type 1 Gaucher's disease.
The Journal of clinical endocrinology and metabolism 1995;80(9):2653-7.
1995: H C van Zaanen; R J Vet; C M de Jong; Albert E G Kr von dem Borne; Marinus H J van Oers
A simple and sensitive method for determining plasma cell isotype and monoclonality in bone marrow using flowcytometry.
British journal of haematology 1995;91(1):55-9.
1995: Carla E M Hollak; johannes aerts; R Goudsmit; Saffire S K S Phoa; M Ek; Sonja van Weely; Albert E G Kr von dem Borne; Marinus H J van Oers
Individualised low-dose alglucerase therapy for type 1 Gaucher's disease.
Lancet 1995;345(8963):1474-8.
1994: Gerrit Koopman; C P Reutelingsperger; G A Kuijten; Robert M J Keehnen; Steven T Pals; Marinus H J van Oers
Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis.
Blood 1994;84(5):1415-20.
1994: Tom W J Huizinga; Masja de Haas; Marinus H J van Oers; Marion Kleijer; H Vilé; P A van der Wouw; A Moulijn; H van Weezel; Mustafa Yavuz Köker; Albert E G Kr von dem Borne
The plasma concentration of soluble Fc-gamma RIII is related to production of neutrophils.
British journal of haematology 1994;87(3):459-63.
1994: Carla E M Hollak; Sonja van Weely; Marinus H J van Oers; johannes aerts
Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.
The Journal of clinical investigation 1994;93(3):1288-92.
1993: Marinus H J van Oers; Steven T Pals; Ludo M Evers; C Ellen van der Schoot; Gerrit Koopman; J M Bonfrer; R Q Hintzen; Albert E G Kr von dem Borne; René A W van Lier
Expression and release of CD27 in human B-cell malignancies.
Blood 1993;82(11):3430-6.
1993: Ari Zimran; Carla E M Hollak; Aya Abrahamov; Marinus H J van Oers; M Kelly; E Beutler
Home treatment with intravenous enzyme replacement therapy for Gaucher disease: an international collaborative study of 33 patients.
Blood 1993;82(4):1107-9.
1993: N H Schut; Wilmar M Wiersinga; Marinus H J van Oers
Methimazole-induced agranulocytosis preceded by transient granulocytopenia. A case report.
The Netherlands journal of medicine 1993;43(1-2):71-3.
1993: Marie José Kersten; M J Mertens; Steven T Pals; Peter Reiss; Marinus H J van Oers
[HIV-related non-Hodgkin lymphoma in 45 patients; a retrospective analysis].
Nederlands tijdschrift voor geneeskunde 1993;137(28):1396-400.
1993: Carla E M Hollak; johannes aerts; Marinus H J van Oers
Treatment of Gaucher's disease.
The New England journal of medicine 1993;328(21):1565-6; author reply 1567.
1993: Marinus H J van Oers; H C van Zaanen; Henk M Lokhorst
Interleukin-6, a new target for therapy in multiple myeloma?
Annals of hematology 1993;66(5):219-23.
1993: O C Leeksma; Marinus H J van Oers; C. Ellen van der Schoot; R Goudsmit; A E von dem Borne
[Primary treatment of acute promyelocytic leukemia using all-trans-retinoic acid].
Nederlands tijdschrift voor geneeskunde 1993;137(16):821-5.
1992: O C Leeksma; L L Thomas; J van der Lelie; Marinus H J van Oers; Albert E G Kr von dem Borne; R Goudsmit
Effectiveness of low dose cyclosporine in acquired aplastic anaemia with severe neutropenia.
The Netherlands journal of medicine 1992;41(3-4):143-8.
1992: K J Tusenius; P J Bakker; Marinus H J van Oers
Measurement of proliferation indices in non Hodgkin's lymphoma--is it useful?
Leukemia & lymphoma 1992;7(3):181-7.
1990: Hanneke Schuitemaker; Neeltje Kootstra; Marinus H J van Oers; R van Lambalgen; M Tersmette; Frank Miedema
Induction of monocyte proliferation and HIV expression by IL-3 does not interfere with anti-viral activity of zidovudine.
Blood 1990;76(8):1490-3.
1990: C Van Kooten; Marinus H J van Oers; Lucien A Aarden
Interleukin-6 enhances human Ig production, but not as a terminal differentiation factor for B lymphocytes.
Research in immunology 1990;141(4-5):341-56.
1989: A A van der Heyden; E Bloemena; T A Out; J M Wilmink; P T A Schellekens; Marinus H J van Oers
The influence of immunosuppressive treatment on immune responsiveness in vivo in kidney transplant recipients.
Transplantation 1989;48(1):44-7.
1989: E Bloemena; René A W van Lier; Marinus H J van Oers; S Weinreich; A P Stilma-Meinesz; P T A Schellekens
The effects of prednisolone and cyclosporin A on monocyte-dependent and -independent human T-cell proliferation in vitro.
Transplantation proceedings 1989;21(1 Pt 1):861-5.
1988: E Bloemena; Marinus H J van Oers; S Weinreich; S L Yong; P T A Schellekens
Prednisolone and cyclosporin A exert differential inhibitory effects on T-cell proliferation in vitro.
Clinical immunology and immunopathology 1988;48(3):380-91.
1988: A A van der Heyden; Marinus H J van Oers; P Cornelissen; S L Yong; J M Wilmink; P T A Schellekens
The influence of cyclosporine A treatment on immune responsiveness in vitro and in vivo in kidney transplant recipients.
Transplantation proceedings 1988;20(2 Suppl 2):190-5.
1988: E Bloemena; Marinus H J van Oers; S Weinreich; S L Yong; P T A Schellekens
Cyclosporine A does not prevent expression of biologically active IL 2 receptors in vitro.
Transplantation proceedings 1988;20(2 Suppl 2):131-5.
1988: Marinus H J van Oers; A A Van der Heyden; Lucien A Aarden
Interleukin 6 (IL-6) in serum and urine of renal transplant recipients.
Clinical and experimental immunology 1988;71(2):314-9.
1988: E Bloemena; Marinus H J van Oers; S Weinreich; P T A Schellekens
Cyclosporin A and prednisolone do not inhibit the expression of high-affinity receptors for interleukin 2.
Clinical and experimental immunology 1988;71(2):308-13.
1987: Marinus H J van Oers; Sugianto Surachno; J M Wilmink
Infiltrate analysis by monoclonal antibodies does not contribute to the usefulness of fine needle aspiration biopsy.
Transplantation proceedings 1987;19(1 Pt 2):1646-9.
1986: Sugianto Surachno; Marinus H J van Oers; J M Wilmink
Early diagnosis of bacterial infection of renal allografts by fine needle aspiration biopsy.
Lancet 1986;1(8482):686-7.